Save time and get answers to complex questions with AI chat
Lipitor vs generics what's the price gap?Somatuline depot patent expiry date?How long have hydroxyzine pamoate been on the market?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Tenofovir generic patent?
See the DrugPatentWatch profile for januvia
Januvia (sitagliptin) – Manufacturing location | Company | Main manufacturing site(s) | Notes | |---------|---------------------------|-------| | Janssen Pharmaceutica N.V. (a Johnson & Johnson subsidiary) | Belgium – 1 Rue de la Tuilerie, 1180 Brussels, Belgium (listed on the FDA label) | This is the primary production facility that supplies the drug for the U.S. and many other markets. | | Johnson & Johnson (Janssen Pharmaceuticals) | United States – Janssen’s manufacturing plant in Westchester, New York (and other U.S. facilities) | The U.S. plant is used to produce the tablets that are sold in the U.S., ensuring local supply and compliance with FDA requirements. | Key points 1. Primary producer: Janssen Pharmaceutica N.V. in Belgium is the official manufacturer listed on the FDA drug label for Januvia. 2. U.S. production: Johnson & Johnson’s Janssen Pharmaceuticals operates U.S. sites (e.g., Westchester, NY) to produce the tablets that are distributed domestically. 3. Global distribution: While the U.S. plant supplies the American market, the Belgian facility is the global manufacturing hub for the drug, with production also occurring in other regions as needed. If you need the most up‑to‑date or detailed manufacturing information, the U.S. FDA’s Drug Label Database (label for sitagliptin) provides the official manufacturer and address.
Other Questions About Januvia :